MRPI - Mera Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Mera Pharmaceuticals, Inc.

8275 S. Easter Avenue
Suite 200
Las Vegas, NV 89123
United States
604 500 4157

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Benny DoroCEO, Interim Director, Pres & Sec.N/AN/A1968
Mr. Lawrence Harris WolfeChief Financial Officer, VP of Fin. and DirectorN/AN/A1963
Ms. Melanie K. KelekolioGen. Mang. of The Operations & Production Facility and VPN/AN/A1968
Ms. Joyce MarkleySec. and DirectorN/AN/A1952
Mr. Rafi MarkariansTreasurer & DirectorN/AN/A1966
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari's system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.

Corporate Governance

Mera Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.